Does Maintenance CBT Contribute to Long-Term Treatment Response of Panic Disorder With or Without Agoraphobia? A Randomized Controlled Clinical Trial

被引:30
|
作者
White, Kamila S. [1 ]
Payne, Laura A. [2 ]
Gorman, Jack M. [3 ]
Shear, M. Katherine [4 ,5 ]
Woods, Scott W. [6 ]
Saksa, John R. [6 ]
Barlow, David H. [7 ,8 ]
机构
[1] Univ Missouri, Dept Psychol, St Louis, MO 63121 USA
[2] Univ Calif Los Angeles, David Geffen Sch Med, Dept Pediat, Pediat Pain Program, Los Angeles, CA 90095 USA
[3] Franklin Behav Hlth Consultants, Bronx, NY USA
[4] Columbia Univ, Dept Psychiat, New York, NY 10027 USA
[5] Columbia Univ, Sch Social Work, New York, NY 10027 USA
[6] Yale Univ, Sch Med, Dept Psychiat, New Haven, CT 06520 USA
[7] Boston Univ, Ctr Anxiety & Related Disorders, Boston, MA 02215 USA
[8] Boston Univ, Dept Psychol, Boston, MA 02215 USA
关键词
maintenance treatment; treatment outcome; panic disorder; randomized controlled clinical trial; cognitive behavior therapy; COGNITIVE-BEHAVIORAL TREATMENT; GENERALIZED ANXIETY DISORDER; STRUCTURED INTERVIEW GUIDE; FOLLOW-UP; RATING-SCALE; THERAPY; PREDICTORS; RELAPSE; IMIPRAMINE; REMISSION;
D O I
10.1037/a0030666
中图分类号
B849 [应用心理学];
学科分类号
040203 ;
摘要
Objective: We examined the possibility that maintenance cognitive behavior therapy (M-CBT) may improve the likelihood of sustained improvement and reduced relapse in a multi-site randomized controlled clinical trial of patients who met criteria for panic disorder with or without agoraphobia. Method: Participants were all patients (N = 379) who first began an open trial of acute-phase CBT. Patients completing and responding to acute-phase treatment were randomized to receive either 9 monthly sessions of M-CBT (n = 79) or assessment only (n = 78) and were then followed for an additional 12 months without treatment. Results: M-CBT produced significantly lower relapse rates (5.2%) and reduced work and social impairment compared to the assessment only condition (18.4%) at a 21-month follow-up. Multivariate Cox proportional hazards models showed that residual symptoms of agoraphobia at the end of acute-phase treatment were independently predictive of time to relapse during 21-month follow-up (hazards ratio = 1.15, p < .01). Conclusions: M-CBT aimed at reinforcing acute treatment gains to prevent relapse and offset disorder recurrence may improve long-term outcome for panic disorder with and without agoraphobia.
引用
收藏
页码:47 / 57
页数:11
相关论文
共 50 条
  • [21] LONG-TERM PHARMACOLOGICAL TREATMENT OF PANIC DISORDER
    BALLENGER, JC
    JOURNAL OF CLINICAL PSYCHIATRY, 1991, 52 : 18 - 23
  • [22] PANIC DISORDER - STRATEGIES FOR LONG-TERM TREATMENT
    KLERMAN, GL
    JOURNAL OF CLINICAL PSYCHIATRY, 1991, 52 : 33 - 33
  • [23] Long-term treatment of panic disorder with benzodiazepines
    Nardi, Antonio E.
    PSYCHOTHERAPY AND PSYCHOSOMATICS, 2019, 88 : 94 - 94
  • [24] LONG-TERM PHARMACOLOGICAL TREATMENT OF PANIC DISORDER
    BALLENGER, L
    JOURNAL OF CLINICAL PSYCHIATRY, 1991, 52 : 24 - 25
  • [25] LONG-TERM PHARMACOLOGICAL TREATMENT OF PANIC DISORDER
    POLLACK, MH
    OTTO, MW
    PSYCHIATRIC ANNALS, 1994, 24 (06) : 291 - 298
  • [26] Long-term citalopram treatment in panic disorder
    Lepola, U
    Wade, A
    Leinonen, E
    Koponen, H
    Sjodin, I
    Penttinen, J
    Lehto, H
    Pedersen, T
    NORDIC JOURNAL OF PSYCHIATRY, 1998, 52 : 83 - 84
  • [27] A RANDOMIZED NATURALISTIC OPEN LONG-TERM TREATMENT OF PANIC DISORDER WITH CLONAZEPAM OR PAROXETINE
    Nardi, A. E.
    Valenca, A. M.
    Freire, R. C.
    Lopes, F. L.
    Nascimento, I.
    King, A. L.
    Sardinha, A.
    Levitan, M. N.
    de Carvalho, M. R.
    de-Melo-Neto, V. L.
    Mezzasalma, M. A.
    Soares-Filho, G. L.
    de Cerqueira, A. C.
    da Costa, R. T.
    Versiani, M.
    EUROPEAN PSYCHIATRY, 2009, 24
  • [28] A randomized controlled clinical trial of psychoanalytic psychotherapy for panic disorder
    Milrod, Barbara
    Leon, Andrew C.
    Busch, Fredric
    Rudden, Marie
    Schwalberg, Michael
    Clarkin, John
    Aronson, Andrew
    Singer, Meriamne
    Turchin, Wendy
    Klass, E. Toby
    Graf, Elizabeth
    Teres, Jed J.
    Shear, M. Katherine
    AMERICAN JOURNAL OF PSYCHIATRY, 2007, 164 (02): : 265 - 272
  • [29] A double-blind placebo-controlled trial comparing fluvoxamine and imipramine in the treatment of panic disorder with or without agoraphobia
    Bakish, D
    Hooper, CL
    Filteau, MJ
    Charbonneau, Y
    Fraser, G
    West, DL
    Thibaudeau, C
    Raine, D
    PSYCHOPHARMACOLOGY BULLETIN, 1996, 32 (01) : 135 - 141
  • [30] Self-guided digital treatment with virtual reality for panic disorder and agoraphobia: a study protocol for a randomized controlled trial
    Planert, Jari
    Machulska, Alla
    Hildebrand, Anne-Sophie
    Roesmann, Kati
    Otto, Esra
    Klucken, Tim
    TRIALS, 2022, 23 (01)